Syncytin-1
Syncytin-1 is a protein that is encoded by the ERVW-1 gene in humans. It is a retroviral envelope protein that mediates the formation of a syncytium, a type of multi-nucleated cell that is formed by the fusion of individual cells. Syncytin-1 is essential for the formation of the placenta during pregnancy, and it has also been implicated in various diseases, including multiple sclerosis and cancer.
Function[edit]
Syncytin-1 is primarily known for its role in the formation of the placenta. It is expressed in the trophoblast cells of the placenta, where it mediates the fusion of these cells to form the syncytiotrophoblast, a multi-nucleated cell layer that is essential for nutrient and gas exchange between the mother and the fetus.
In addition to its role in placental development, syncytin-1 has also been implicated in the pathogenesis of various diseases. For example, it has been found to be overexpressed in certain types of cancer, including breast cancer and endometrial cancer, where it may promote tumor growth and metastasis. Furthermore, it has been suggested that syncytin-1 may play a role in the development of multiple sclerosis, a chronic disease of the nervous system, although the exact mechanisms are still under investigation.
Structure[edit]
Syncytin-1 is a type I transmembrane protein, meaning that it spans the cell membrane once. It consists of a large extracellular domain, a transmembrane domain, and a short intracellular domain. The extracellular domain is responsible for mediating cell-cell fusion, while the transmembrane domain anchors the protein in the cell membrane.
Clinical significance[edit]
Given its role in placental development and disease pathogenesis, syncytin-1 is a potential target for therapeutic intervention. For example, drugs that inhibit the function of syncytin-1 could potentially be used to treat cancers that overexpress this protein. Similarly, modulating the activity of syncytin-1 could potentially be used to treat diseases like multiple sclerosis, although more research is needed in this area.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian